Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade

通过血小板反应蛋白-1 阻断使衰老的造血干细胞和内皮微环境恢复活力

基本信息

  • 批准号:
    10634625
  • 负责人:
  • 金额:
    $ 49.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-23 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY There is a substantial need for the development of preventative and therapeutic options to delay the aging process, to rejuvenate tissue/organs, and to enhance regeneration and repair. Aging of the blood system is associated with loss of vascular integrity and dramatic changes in hematopoietic stem cell (HSC) function. In addition to increasing in number and losing self-renewal potential, old HSCs exhibit a myeloid bias and increased propensity to develop hematologic malignancies. While some of these changes reflect cell-intrinsic alterations, emerging evidence suggests that some of these defects may also be regulated by the bone marrow (BM) microenvironment, in particular the BM endothelial niche. In particular, we have demonstrated that the BM endothelial niche is indispensable for supporting the balance between HSC self-renewal and differentiation following myeloablative insult. We have also shown that AKT/mTOR signaling in BM endothelial cells (BMECs) is required for maintenance of the HSCs and that this signaling is disrupted in aged BMECs. To ask how a disruption of the AKT/mTOR signaling axis in ECs affects the hematopoietic system, we have conditionally deleted mTOR in adult ECs (mTOR(ECKO) mice) and found that this deletion resulted in the premature aging of HSCs as demonstrated by their phenotypic, functional, and transcriptional analysis. To better understand how EC-mediated signaling drives the aging of the hematopoietic system, we utilized our mTOR(ECKO) mouse model as a screening tool to discover as yet unknown pro-HSC-aging factors. Transcriptomic and proteomic studies identified Thrombospondin-1 (TSP1) as a candidate pro-aging factor that was commonly upregulated in mTOR(ECKO) and aged mice when compared to young controls. Moreover, global knockout of TSP1 resulted in preservation and rejuvenation of HSC function in aged mice. This research proposal is designed to test whether it is possible to: 1) reverse the age-related phenotypes of the hematopoietic and vascular systems by global or cell-specific deletion, or antibody-mediated inhibition, of TSP1, 2) enhance the ex vivo expansion and function of aged HSC by exogenous inhibition of TSP1, and 3) rejuvenate an aged BM microenvironment following myelosuppressive treatments by utilizing young BMECs as a cellular therapeutic with or without the co-infusion of a neutralizing antibody to TSP1. The proposed studies will utilize novel in vivo and in vitro models developed in our lab and, if successful, will unlock the therapeutic potential of TSP1 inhibition to improve overall healthspan, longevity, and regeneration of the hematopoietic system in the elderly. The success of this research proposal will open up new avenues for the development of a wide array of therapeutic strategies designed as an effective means to reverse age-related hematopoietic deficiencies.
项目概要 迫切需要开发预防和治疗方案来延缓衰老 过程,使组织/器官恢复活力,并增强再生和修复。血液系统的老化是 与血管完整性丧失和造血干细胞(HSC)功能的巨大变化有关。在 除了数量增加和失去自我更新潜力外,旧的 HSC 还表现出骨髓偏向性,并且增加 发生血液系统恶性肿瘤的倾向。虽然其中一些变化反映了细胞内在的改变, 新出现的证据表明,其中一些缺陷也可能受到骨髓 (BM) 的调节 微环境,特别是骨髓内皮细胞微环境。特别是,我们已经证明了 BM 内皮生态位对于支持 HSC 自我更新和分化之间的平衡是不可或缺的 清髓性损伤后。我们还发现 BM 内皮细胞 (BMEC) 中的 AKT/mTOR 信号传导 是维持 HSC 所必需的,但这种信号在老化的 BMEC 中会被破坏。要问如何一个 EC 中 AKT/mTOR 信号轴的破坏会影响造血系统,我们有条件地 在成年EC(mTOR(ECKO)小鼠)中删除mTOR,发现这种删除导致了早衰 通过表型、功能和转录分析证明 HSC。为了更好地理解如何 EC 介导的信号传导驱动造血系统老化,我们利用我们的 mTOR(ECKO) 小鼠模型 作为发现尚未知的促 HSC 衰老因子的筛查工具。转录组学和蛋白质组学研究 确定 Thrombospondin-1 (TSP1) 是一种候选促衰老因子,在 mTOR(ECKO) 和老年小鼠与年轻对照组相比。此外,TSP1 的全局敲除导致 老年小鼠 HSC 功能的保存和恢复。本研究计划旨在测试是否 有可能:1)通过整体或逆转造血和血管系统与年龄相关的表型 TSP1 的细胞特异性缺失或抗体介导的抑制,2) 增强离体扩增和功能 通过外源性抑制 TSP1 来抑制老化的 HSC,以及 3) 使老化的 BM 微环境恢复活力 利用年轻的 BMEC 作为细胞治疗剂(有或没有共输注)进行骨髓抑制治疗 TSP1 的中和抗体。拟议的研究将利用开发的新型体内和体外模型 在我们的实验室中,如果成功,将释放 TSP1 抑制的治疗潜力,以改善整体健康寿命, 长寿和老年人造血系统的再生。本研究计划的成功 将为开发一系列广泛的治疗策略开辟新的途径,这些策略被设计为有效的 意味着逆转与年龄相关的造血缺陷。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Restoring bone marrow niche function rejuvenates aged hematopoietic stem cells by reactivating the DNA Damage Response.
恢复骨髓生态位功能可通过重新激活 DNA 损伤反应来恢复衰老的造血干细胞的活力。
  • DOI:
  • 发表时间:
    2023-04-10
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Ramalingam, Pradeep;Gutkin, Michael C;Poulos, Michael G;Tillery, Taylor;Doughty, Chelsea;Winiarski, Agatha;Freire, Ana G;Rafii, Shahin;Redmond, David;Butler, Jason M
  • 通讯作者:
    Butler, Jason M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jason Mathew Butler其他文献

Jason Mathew Butler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jason Mathew Butler', 18)}}的其他基金

Preserving bone marrow niche integrity and function to rejuvenate aged hematopoietic stem cells
保护骨髓生态位的完整性和功能,使老化的造血干细胞恢复活力
  • 批准号:
    10735925
  • 财政年份:
    2023
  • 资助金额:
    $ 49.57万
  • 项目类别:
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
通过血小板反应蛋白-1 阻断使衰老的造血干细胞和内皮微环境恢复活力
  • 批准号:
    10709177
  • 财政年份:
    2022
  • 资助金额:
    $ 49.57万
  • 项目类别:
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
通过血小板反应蛋白-1 阻断使衰老的造血干细胞和内皮微环境恢复活力
  • 批准号:
    10200637
  • 财政年份:
    2019
  • 资助金额:
    $ 49.57万
  • 项目类别:
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
通过血小板反应蛋白-1 阻断使衰老的造血干细胞和内皮微环境恢复活力
  • 批准号:
    10026020
  • 财政年份:
    2019
  • 资助金额:
    $ 49.57万
  • 项目类别:
Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
通过血小板反应蛋白-1 阻断使衰老的造血干细胞和内皮微环境恢复活力
  • 批准号:
    10431964
  • 财政年份:
    2019
  • 资助金额:
    $ 49.57万
  • 项目类别:
Modulating endothelial-specific signaling to enhance functional hematopoiesis.
调节内皮特异性信号传导以增强功能性造血功能。
  • 批准号:
    9149403
  • 财政年份:
    2016
  • 资助金额:
    $ 49.57万
  • 项目类别:
Modulating signaling pathways in endothelial cells to abate leukemic progression
调节内皮细胞信号通路以减缓白血病进展
  • 批准号:
    9893715
  • 财政年份:
    2016
  • 资助金额:
    $ 49.57万
  • 项目类别:

相似国自然基金

本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目

相似海外基金

Preserving Physical Function in Older Adults with Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
保留患有癌症的老年人的身体功能:手术前后应用优化营养干预的影响
  • 批准号:
    10643468
  • 财政年份:
    2023
  • 资助金额:
    $ 49.57万
  • 项目类别:
Development and Validation of the Down Syndrome Regression Rating Scales
唐氏综合症回归评定量表的开发和验证
  • 批准号:
    10781052
  • 财政年份:
    2023
  • 资助金额:
    $ 49.57万
  • 项目类别:
UAS-CLEAR: A new nationally representative longitudinal study of caregiving experiences and well-being across the lifecourse
UAS-CLEAR:一项新的全国代表性纵向研究,涉及整个生命过程中的护理体验和福祉
  • 批准号:
    10729032
  • 财政年份:
    2023
  • 资助金额:
    $ 49.57万
  • 项目类别:
Muscle Mass: a Critical but Missing Component in Muscle Modeling and Simulation
肌肉质量:肌肉建模和模拟中关键但缺失的组成部分
  • 批准号:
    10586547
  • 财政年份:
    2023
  • 资助金额:
    $ 49.57万
  • 项目类别:
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
  • 批准号:
    10584712
  • 财政年份:
    2023
  • 资助金额:
    $ 49.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了